What's happening
This bill prohibits drug, cannabis, or alcohol testing and screening of pregnant or postpartum individuals and newborns without informed consent, except in emergencies.
Why it matters
Strengthens patient autonomy and privacy. The bill ensures that pregnant or postpartum individuals, and parents of newborns, must provide informed consent before any drug, cannabis, or alcohol testing or screening, giving patients more control over their medical information and decisions.
Reduces risk of legal and child welfare consequences from non-medical testing. By requiring explicit consent and notification of potential legal consequences (such as reporting to child protective services), the bill aims to protect families from unintended legal jeopardy stemming from routine or non-consensual tests.
Limits potential for discriminatory or coercive practices. The law addresses concerns that drug and alcohol testing during pregnancy or after childbirth can be disproportionately used against marginalized groups, and aims to prevent coercion or undue influence in obtaining consent.
Preserves emergency medical care flexibility. Exceptions are made for true medical emergencies where delaying testing could harm the patient or newborn, ensuring that urgent care is not impeded while still mandating post-test notification and documentation.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Ban Nonconsensual Pregnancy Drug Tests
Plain English, a few words. Used as the page title.
Sponsors
History
- Referred to women's issues
- Print number 320b
- Amend (t) and recommit to women's issues
- Print number 320a
- Amend and recommit to women's issues
- Referred to women's issues
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Stop Testing Pregnant People
Assembly Floor Calendar · Sponsor Linda Rosenthal
Full text
3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
320--B
2023-2024 Regular Sessions
IN SENATE (Prefiled)
January 4, 2023
Introduced by Sens. SALAZAR, BRISPORT, BROUK, CLEARE, COONEY, FERNANDEZ, GOUNARDES, JACKSON, KRUEGER, MYRIE, RIVERA, SEPULVEDA, SERRANO, WEBB -- read twice and ordered printed, and when printed to be committed to the Committee on Women's Issues -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee -committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the public health law, in relation to prohibiting drug, cannabis or alcohol testing and screening of pregnant or postpartum individuals and newborns
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The public health law is amended by adding a new section 2509-b to read as follows:
§ 2509-b. Drug, cannabis or alcohol testing and screening for pregnant or postpartum individuals; prohibited. 1. For purposes of this section:
(a) "drug" shall mean a controlled substance as that term is defined in section thirty-three hundred six of this chapter.
(b) "cannabis" shall mean cannabis or concentrated cannabis as those terms are defined in section 222.00 of the penal law.
(c) "drug, cannabis or alcohol test" shall mean a test using a biological sample, including, but not limited to, urine or hair, for the presence of drugs, cannabis or alcohol.
(d) "drug, cannabis or alcohol screen" shall mean the use of a validated verbal or written tool or questionnaire by a health care professional licensed, certified, or authorized under title eight of the education law to determine use of drugs, cannabis or alcohol by a pregnant or postpartum person.
2. No health care professional licensed, certified, or authorized under title eight of the education law shall:
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD00489-05-3
(a) perform a drug, cannabis or alcohol test on a person who is pregnant or up to one year postpartum unless:
(i) the pregnant or postpartum individual gives prior written and oral informed consent specific to the drug, cannabis or alcohol test; and
(ii) the performance of the drug, cannabis or alcohol test is within the scope of medical care being provided to the individual, cannabis.
(b) perform a drug, cannabis or alcohol screen in a hospital on a person who is pregnant or up to one year postpartum unless:
(i) the pregnant or postpartum individual gives prior written and oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the individual.
(c) perform a drug, cannabis or alcohol screen outside a hospital on a person who is pregnant or up to one year postpartum unless:
(i) the pregnant or postpartum individual gives prior oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the individual.
3. No health care professional licensed, certified or authorized under title eight of the education law shall:
(a) perform a drug, cannabis or alcohol test on a newborn unless:
(i) the individual authorized to consent for the newborn, as defined by subdivision two of section twenty-five hundred four of this title, gives prior written and oral informed consent specific to the drug, cannabis or alcohol test; and
(ii) the performance of the drug, cannabis or alcohol test is within the scope of medical care being provided to the newborn;
(b) perform a drug, cannabis or alcohol screen in a hospital on a newborn unless:
(i) the individual authorized to consent for the newborn, as defined by subdivision two of section twenty-five hundred four of this title, gives prior written and oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the newborn;
(c) perform a drug, cannabis or alcohol screen outside a hospital on a newborn unless:
(i) the individual authorized to consent for the newborn, as defined by subdivision two of section twenty-five hundred four of this title, gives prior oral informed consent specific to the drug, cannabis or alcohol screen; and
(ii) the performance of the drug, cannabis or alcohol screen is within the scope of medical care being provided to the newborn.
4. Written and oral informed consent to a drug, cannabis or alcohol test or drug or alcohol screen shall occur at the time of testing, in language understandable to the pregnant or postpartum individual, or the individual authorized to consent for the newborn, under circumstances that provide such individual sufficient opportunity to consider whether or not to authorize the drug, cannabis or alcohol test or drug, cannabis or alcohol screen and minimize the possibility of coercion or undue influence, and shall consist of oral authorization and written authorization that is dated, signed and includes the following:
(a) a statement explaining that consenting to a drug, cannabis or alcohol test or drug, cannabis or alcohol screen is voluntary and requires written and oral informed consent, except when conditions under subdivision five of this section are met;
(b) a statement that testing or screening positive for drugs, cannabis or alcohol could have legal consequences, including, but not limited to, a report to a local child protective services agency, and that the individual may want to consult with legal counsel prior to or after consenting to a drug, cannabis or alcohol test or drug, cannabis or alcohol screen;
(c) a statement explaining the extent of confidentiality of the test or screen results;
(d) a statement of the medical purpose of the test or screen; and
(e) a general description of the test or screen.
5. Drug, cannabis or alcohol testing or drug, cannabis or alcohol screening may be performed without consent of the patient or the individual authorized to consent for a newborn when, in the health care professional's judgment, an emergency exists and the patient or newborn is in immediate need of medical attention, and an attempt to secure consent would result in delay of treatment that could increase the risk to the patient's or newborn's life or health. In the case that drug, cannabis or alcohol testing or drug or alcohol screening is performed under these circumstances, the test or screen results shall be discussed with the patient or the individual authorized to consent for the newborn, in language understandable to the patient or individuals authorized to consent for the newborn and shall consist of oral notification and written notification that is dated, signed and includes the following:
(a) a statement that testing or screening positive for drugs, cannabis or alcohol could have legal consequences, including but not limited to a potential report to a local child protective services agency, and that the patient or individual authorized to consent for the newborn may want to consult with legal counsel;
(b) a statement in the medical record with a description of the emergency that necessitated unconsented drug, cannabis or alcohol testing or drug, cannabis or alcohol screening; and
(c) a statement explaining the extent of confidentiality of the test or screen results.
6. No health care professional licensed, certified, or authorized under title eight of the education law shall refuse to treat an individual who is pregnant or up to one year postpartum or a newborn because of the patient or individuals authorized to consent for the newborn's refusal to submit to a drug, cannabis or alcohol test or drug, cannabis or alcohol screen.
7. Nothing in this section shall diminish any other requirement to obtain informed consent for a drug, cannabis or alcohol test or drug, cannabis or alcohol screen or any other procedure.
§ 2. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the public health law, in relation to prohibiting drug, cannabis or alcohol testing and screening of pregnant or postpartum individuals and newborns
Purpose
This bill preserves the trust between a pregnant or perinatal person and their healthcare provider by prohibiting drug testing without informed consent.
Summary of specific provisions
Section one amends the public health law by adding a new section 2509-b, which requires clear and informed consent from pregnant or post-partum people regarding drug or alcohol tests and screenings of the pregnant or post-partum person or of a newborn and defines "drug", "drug or alcohol test", and "drug or alcohol screen".
Section two establishes the effective date.
Justification
When a pregnant person comes to a hospital or medical provider seeking medical care, there is an expectation that they will receive only services to which they consent and seek. The involuntary or uninformed drug testing of pregnant and perinatal persons not only runs counter to this, but it serves as a disincentive to the pursuit of medical support during pregnancy and in childbirth. New York State currently ranks 30th among all states with a maternal mortality rate at 25 deaths per 100,000 live births.
Pregnant persons who engage in substance use face significant barriers to seeking treatment, general medical care, and pre-natal care. Amongst these barriers is the fear of judgment by healthcare providers, and more importantly, the risk of a child protective services investigation, loss of the child and/or criminal justice repercussions.(1) In cases where a doctor deems it necessary to perform an emergency drug test on an inca- pacitated patient, unable to consent to such testing, it is equally vital that the results of this testing be kept confidential and not used for any purpose outside of medical diagnosis and treatment.
This legislation prohibits physicians or other medical personnel from conducting drug testing of a pregnant or perinatal person or their newborn without informed consent being provided, unless such testing is necessary for emergency purposes. This legislation will help to preserve the necessary trust between a pregnant or perinatal person in need of medical care and support, and their provider, and will remove a poten- tial disincentive to seeking care.
SOCIAL JUSTICE IMPACT
Pregnant individuals seeking medical care should not be exposed to crim- inal or civil penalties or the risk of losing their child, particularly when the existence of such potential penalties often serves as a disin- centive to seek medical care. Rather, in order to reduce infant and maternal mortality and to encourage the provision of proper medical care, full informed consent regarding any drug or alcohol testing or screening is necessary. Resources should be provided by medical provid- ers to reduce harm and potential complications. It is crucial to recog- nize substance abuse disorder as a debilitating disorder, and not as a criminal behavior.
AMENDED BILL
The "B" print explicitly includes "cannabis" separately from "drugs" to address changes in the law after the enactment of the Marijuana Regu- lation & Taxation Act, Chapter 92 of the Laws of 2021.
Senate
2021-2022: S4821A (Salazar)- Referred to Women's Issues
Assembly
2019-2020: A5478A (Rosenthal)- Referred to Governmental Operations
2021: A4285A (Rosenthal)- Referred to Governmental Operations, Referred to Health
2022: A4285A- Referred to Health, Referred to Codes, Referred to Rules
Fiscal implications
No fiscal implications to state or local government are anticipated.
Effective date
This act shall take effect immediately. (1) https://sph.unc.edu/sph-news/prenatal-substance-use-linked- to-in- adequate-prenatal-perinatal-care/
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.